Friday, November 20, 2026

"H.PIO Co., Ltd. Expected to Expand Its China Business and Improve Profitability"

Input
2026-11-20 16:15:41
Updated
2026-11-20 16:15:41
H.PIO Co., Ltd. CI. Provided by H.PIO Co., Ltd.

[Financial News] Independent research firm Bullet said it expects H.PIO Co., Ltd.'s stock to be re-rated, driven by an expansion of its China business and improved profitability in health functional foods. It recommended a “Buy” rating but did not provide a target price.
Bullet researcher Ahn Byung-wook said on the 20th, “H.PIO Co., Ltd. is seeing results in the Chinese market through its Denps Shanghai subsidiary,” adding that it “is expanding its online and offline sales channels, focusing on major distributors such as JD.com and Sam’s Club.”
H.PIO Co., Ltd.'s consolidated revenue for the first three quarters of this year totaled 213.5 billion won, up about 10% from the same period last year and a record high. Operating profit came to 7.9 billion won. Revenue at Denps Shanghai in the third quarter was 15.5 billion won, up 11.6% year over year. Expectations that China’s restrictions on Korean cultural content would ease, following progress in follow-up negotiations on the Korea-China Free Trade Agreement (FTA), were also cited as a positive factor for expanding the China business.
Researcher Ahn said, “The euro exchange rate rose to as high as 1,730 won in the first half, increasing the cost burden of imported probiotics, and the cost of inventory brought in when exchange rates were high was reflected in third-quarter results.” He forecast that “the average won-euro exchange rate fell to around 1,500 won in October, easing cost pressures and raising expectations for profit growth going forward.”

[email protected] Im Sang-hyeok Reporter